en
Scientific article
English

Aplasia cutis congenita in surviving co-twin after propylthiouracil exposure in utero

Published inJournal of pediatric endocrinology & metabolism, vol. 24, no. 3-4, p. 215-218
Publication date2011
Abstract

Aplasia cutis congenita (ACC) has been observed after fetal exposure to the antithyroid drug methimazole (MMI), but not reported after propylthiouracil (PTU), the current antithyroid drug of choice during pregnancy. This occurrence has implications for patient information and causal research.

Keywords
  • Abnormalities, Drug-Induced/etiology/pathology
  • Antithyroid Agents/adverse effects
  • Diseases in Twins/etiology/pathology
  • Ectodermal Dysplasia/etiology/pathology
  • Female
  • Gestational Age
  • Graves Disease/complications/diagnosis/drug therapy
  • Humans
  • Infant, Newborn
  • Maternal Exposure
  • Pregnancy
  • Pregnancy Complications/diagnosis/drug therapy
  • Propylthiouracil/adverse effects
Citation (ISO format)
LÖLLGEN, Ruth M et al. Aplasia cutis congenita in surviving co-twin after propylthiouracil exposure in utero. In: Journal of pediatric endocrinology & metabolism, 2011, vol. 24, n° 3-4, p. 215–218. doi: 10.1515/jpem.2011.099
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0334-018X
505views
0downloads

Technical informations

Creation12/17/2012 3:49:00 PM
First validation12/17/2012 3:49:00 PM
Update time03/14/2023 7:58:45 PM
Status update03/14/2023 7:58:45 PM
Last indexation01/16/2024 1:00:40 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack